Diet Intervention Clinical Trial
Official title:
Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome
This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.
Status | Not yet recruiting |
Enrollment | 90 |
Est. completion date | December 1, 2027 |
Est. primary completion date | December 1, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Age: 18-45 years of age - BMI: 18-35 kg/m2 - Willingness to consume study foods. - Willing to comply with study protocol. - Consistent diet and activity patterns for 4 weeks - Weight stable (=5 kg change over the last 3 months) - Non-smoker >1 year or more Exclusion Criteria: - Allergies to foods provided in the study - Diabetes - Gastrointestinal disease and/or bariatric surgery - Uncontrolled hypertension and blood pressure = 180/110 - Illicit drug use - Recent consumption of antibiotics - Recent start of medications that affect metabolism or appetite. - Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia - Pregnant or lactating individuals - Taste or smell disorders |
Country | Name | City | State |
---|---|---|---|
United States | University of Missouri-Columbia | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Metabolite intensities | Untargeted and targeted metabolomics | Baseline, week 6 | |
Other | Nutrient intakes | 24 hours dietary recall | Baseline, week 3, week 6 | |
Primary | LDL-C concentrations | Lipid profile | Baseline, week 6 | |
Primary | Interleukin-6 concentrations | Inflammatory marker | Baseline, week 6 | |
Primary | Gut microbial alpha-diversity | Assessed via16S rRNA sequencing | Baseline, week 6 | |
Secondary | HDL-C concentrations | Lipid profile | Baseline, week 6 | |
Secondary | Total cholesterol concentrations | Lipid profile | Baseline, week 6 | |
Secondary | Triglyceride concentrations | Lipid profile | Baseline, week 6 | |
Secondary | Gut microbiome abundance | 16S rRNA sequencing | Baseline, week 6 | |
Secondary | LPS-binding protein concentration | Intestinal permeability marker | Baseline, week 6 | |
Secondary | Glucose concentrations | Blood Glucose | Baseline, week 6 | |
Secondary | Insulin concentrations | Insulin | Baseline, week 6 | |
Secondary | Body mass | Measured in kg | Baseline, week 3, and week 6 | |
Secondary | Fat mass | Fat mass | Baseline, week 3, and week 6 | |
Secondary | Fat-free mass | Fat-free mass | Baseline, week 3, and week 6 | |
Secondary | Waist circumference | Waist circumference | Baseline, week 3, and week 6 | |
Secondary | Hip circumference | Hip Circumference | Baseline, week 3, and week 6 | |
Secondary | Thigh circumference | Thigh Circumference | Baseline, week 3, and week 6 | |
Secondary | 24 hour appetite ratings | 24-hour appetite ratings assessed on VAS | Baseline, week 6 | |
Secondary | Physical activity scores | Activity assessment using Actigraphs | Baseline, week 6 | |
Secondary | Total hours of sleep | Sleep diary | Baseline, week 6 | |
Secondary | Palatability rating of foods | Hedonic general labelled magnitude scale (gLMS) | Baseline, week 3, week 6 | |
Secondary | Acceptance rating of foods | 9-point food action rating scale | Baseline, week 3, week 6 | |
Secondary | Taste and flavor intensity ratings of foods | Sensory intensity scales | Baseline | |
Secondary | Gene expression levels | Transcriptomics analyses | Baseline, week 6 | |
Secondary | Inflammatory marker concentrations | Inflammatory markers | Baseline, week 6 | |
Secondary | Healthy eating index score | NCI diet history questionnaire | Baseline, week 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05530499 -
Effects of Almonds on Immune Health and Responsiveness
|
N/A | |
Not yet recruiting |
NCT05039060 -
Modified MAC Diet and Gut Microbiota in CRC Patients
|
N/A | |
Completed |
NCT04545346 -
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
|
N/A | |
Completed |
NCT05844085 -
Effects of Plant-based Polar Lipids on Acute and Second Meal Glucose Tolerance and Appetite Sensations
|
N/A | |
Completed |
NCT03084003 -
Effects of Almond Consumption on Cardiovascular, Metabolomic, and Microbiome Profiles in Millennials
|
N/A | |
Recruiting |
NCT04635917 -
Effects of a Personalized Diet on Cardiometabolic, Microbiome and Metabolomics Profiles in Minority Young Adults
|
N/A | |
Not yet recruiting |
NCT06273631 -
Effect of Changes in Carbohydrate Intake on Glucose Control in Patients With Type 1 Diabetes
|
N/A |